Fujifilm Corporation: FDA filings under this applicant name
FDA lists 71 510(k) clearances under the applicant name “Fujifilm Corporation” (first 2018, latest 2026), across 22 product codes in 4 review panels. Median 510(k) review time under this name: 128 days. Since 2017 the median was 128 days, against 118 days for all cleared 510(k)s in the same product codes. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Fujifilm Healthcare, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2018 | 7 | 67 |
| 2019 | 20 | 108 |
| 2020 | 6 | 62 |
| 2021 | 5 | 53 |
| 2022 | 6 | 133 |
| 2023 | 2 | 267 |
| 2024 | 3 | 32 |
| 2025 | 8 | 173 |
| 2026 | 14 | 154 |
Review time against the same product codes
Since 2017, 510(k)s cleared under the name Fujifilm Corporation took a median 128 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 118 days.
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| FDS | Gastroscope And Accessories, Flexible/Rigid | 15 | 15 |
| EOQ | Bronchoscope (Flexible Or Rigid) | 6 | 6 |
| LLZ | System, Image Processing, Radiological | 6 | 6 |
| FDF | Colonoscope And Accessories, Flexible/Rigid | 5 | 5 |
| FDT | Duodenoscope And Accessories, Flexible/Rigid | 5 | 5 |
| LNH | System, Nuclear Magnetic Resonance Imaging | 4 | 4 |
| ODG | Endoscopic Ultrasound System, Gastroenterology-Urology | 4 | 4 |
| FDA | Enteroscope And Accessories | 3 | 3 |
| FET | Endoscopic Video Imaging System/Component, Gastroenterology-Urology | 3 | 3 |
| JAK | System, X-Ray, Tomography, Computed | 3 | 3 |
Plus 12 more product codes.
Review panels
- Gastroenterology and Urology (40)
- Radiology (23)
- Ear, Nose and Throat (6)
- General and Plastic Surgery (2)
Most recent Fujifilm Corporation 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K262902 | ECHELON Synergy | LNH | 2026-10-09 | 52 |
| K261229 | SCENARIA View Phase 6.0 | JAK | 2026-09-18 | 156 |
| K261283 | APERTO Lucent MRI System | LNH | 2026-09-16 | 152 |
| K253836 | FCT iStream Phase 2 | JAK | 2026-09-04 | 277 |
| K261170 | BA-004CC | ITX | 2026-08-12 | 125 |
| K260567 | EW10-EC02 Endoscopy Support Program | QNP | 2026-08-07 | 169 |
| K261880 | FUJIFILM Processor EP-8000;Balloon Controller PB-30;Endoscopy Support Program EW10-VM01 | FET | 2026-07-02 | 27 |
| K253137 | FUJIFILM Endoscope Model EB-840S; FUJIFILM Endoscope Model EB-840T | EOQ | 2026-06-16 | 264 |
| K254075 | Synapse Lung Nodule AI | OEB | 2026-05-27 | 160 |
| K254189 | Synapse 3D Base Tools (V7.2) | QIH | 2026-04-30 | 128 |
61 earlier clearances. See the full list in Caduvo.
Recalls
FDA recall records list no recalls under a recalling firm named Fujifilm Corporation.
11 product recalls in 6 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 9 initiated in the last five years. Most often: FUJIFILM Healthcare Americas Corporation (9), Fujifilm Medical Systems U.S.A., Inc. (2).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
Related HCPCS codes
HCPCS Level II codes whose descriptors match the device names of the product codes filed under Fujifilm Corporation (a text match, not an official crosswalk):
- C8903 — Magnetic resonance imaging with contrast, breast; unilateral (via LNH)
- C8906 — Magnetic resonance imaging with contrast, breast; bilateral (via LNH)
- C8905 — Magnetic resonance imaging without contrast followed by with contrast, breast; unilateral (via LNH)
- C8908 — Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral (via LNH)
- C8900 — Magnetic resonance angiography with contrast, abdomen (via LNH)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Fujifilm Medical System U.S.A., Inc. (71 510(k)s)
- Fujifilm Medical Systems U.S.A, Inc. (39 510(k)s)
- FUJIFILM Sonosite, Inc. (25 510(k)s)
- FUJIFILM Healthcare Americas Corporation (13 510(k)s)
- Fujifilm Corporaton (6 510(k)s)
- Fujifilm Healthcare Corporation (6 510(k)s)
- Fujifilm Irvine Scientific (5 510(k)s)
- Fujifilm New Development U.S.A., Inc. (3 510(k)s)
- Fujifilm Medwork GmbH (2 510(k)s)
- Fujifilm Meidcal Systems U.S.A.,Inc. (2 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Fujifilm Corporation?
FDA lists 71 510(k) clearances under the applicant name “Fujifilm Corporation” (first 2018, latest 2026), across 22 product codes in 4 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Fujifilm Corporation?
The median time from FDA receipt to decision across 510(k)s cleared under the name Fujifilm Corporation is 128 days. Since 2017: 128 days, versus 118 days for all cleared 510(k)s in the same product codes.
Which FDA product codes appear under Fujifilm Corporation?
The most frequent FDA product codes under this applicant name are FDS (Gastroscope And Accessories, Flexible/Rigid, 15); EOQ (Bronchoscope (Flexible Or Rigid), 6); LLZ (System, Image Processing, Radiological, 6).
Next steps
- See all 71 Fujifilm Corporation clearances with predicates and recalls
- Run predicate analysis for product code FDS, Fujifilm Corporation's most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant name shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.